{"id":"NCT01777308","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination","officialTitle":"The Vaccine Response and Long-term Antibody Persistence of GSK Biologicals' MenACWY-TT Vaccine (GSK134612) Administered as One Dose at 6 Years Post-MenC Primary Vaccination in Healthy Subjects Aged 12-18 Months at Primary Vaccination","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05-03","primaryCompletion":"2014-07-03","completion":"2016-04-20","firstPosted":"2013-01-28","resultsPosted":"2019-01-25","lastUpdate":"2019-01-25"},"enrollment":156,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Meningococcal"],"interventions":[{"type":"BIOLOGICAL","name":"Meningococcal conjugate vaccine GSK134612","otherNames":[]}],"arms":[{"label":"Menitorix Group","type":"EXPERIMENTAL"},{"label":"Meningitec + Hiberix Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the immunogenicity, reactogenicity and safety of a booster dose of GSK Biologicals' MenACWY-TT vaccine administered at 6 years post-primary vaccination with either GSK Biologicals' Hib-MenC-TT vaccine (Menitorix™) or Hiberix™ and Meningitec™, in healthy subjects aged 12-18 months at primary vaccination and to evaluate the long-term antibody persistence at 2 years after MenACWY-TT booster vaccination.\n\nThis is an extension study of the Hib-MenC-TT-016 study (NCT number: NCT00326118).","primaryOutcome":{"measure":"Number of Subjects With Vaccine Response for Serum Bactericidal Assay Using Rabbit Complement Against Neisseria Meningitides Serogroup A, C, W-135 and Y (rSBA-MenA, rSBA-MenC, rSBA-MenW-135, rSBA-MenY)","timeFrame":"At Month 73, one month post-booster vaccination","effectByArm":[{"arm":"Menitorix Group","deltaMin":102,"sd":null},{"arm":"Meningitec + Hiberix Group","deltaMin":33,"sd":null}],"pValues":[]},"eligibility":{"minAge":"84 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":8,"countries":["Australia"]},"refs":{"pmids":["31116180"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":119},"commonTop":["Pain","Erythema","Fatigue","Swelling","Headache"]}}